Related Experiment Video
Updated: Apr 17, 2026

Extraction and Analysis of Taiwanese Green Propolis
Published on: January 7, 2019
Antihyperglycemic effects of Pandanus amaryllifolius Roxb. leaf extract
Anchalee Chiabchalard1, Nattakarn Nooron2
1Department of Clinical Chemistry, Faculty of Allied Health Sciences, Center for Excellence in Omics-Nano Medical Technology Development Project, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
Background:
Diabetes mellitus is one of the leading chronic diseases worldwide. In patients with poor glycemic control, high blood glucose level may lead to other life-threatening complications. Pandanus amaryllifolius Roxb. (PA) leaves are used in traditional medicine for the treatment of diabetes.
Objective:
This study evaluated the effect of crude extract from PA leaves on blood glucose level and the hypoglycemic mechanisms.
Materials And Methods:
Thirty healthy volunteers were asked to drink PA tea (test-group) or hot water (control group) 15 min after glucose loading (75 g) in a standard oral glucose tolerance test. To study hypoglycemic mechanisms, PA leaves were extracted using two different methods. Method 1; dried PA leaves were extracted with distilled water at 90°C for 15 min, and method 2; dried PA leaves were extracted with 95% ethanol. Both PA extracts were tested for α-glucosidase enzyme inhibition, insulin stimulation, and glucose uptake stimulation.
Results:
The average of blood glucose level in the control group was 5.55 ± 0.98 mmol/l, while in PA treated group was 6.16 ± 0.79 mmol/l which were statistically different (P < 0.001). The results of antihyperglycemic mechanism showed that PA extracts, prepared both methods, could inhibit α-glucosidase enzyme and induce insulin production in rat pancreatic cell (RINm5F) in dose-dependent manner (P < 0.05).
Conclusions:
The knowledge gained from this research can be used as a basis for a new drug discovery for the treatment of diabetes.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

